S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

IBM Advances to Stage C of DARPA Quantum Benchmarking Initiative

The U.S. Defense Advanced Research Projects Agency has selected IBM for the third phase of its Quantum Benchmarking Initiative. This milestone shifts the company from theoretical planning to rigorous independent hardware verification, as DARPA evaluates which organizations can realistically deliver a fault-tolerant quantum computer by 2033.

IBM Advances to Stage C of DARPA Quantum Benchmarking Initiative
Photo: Bio & News

Jay Gambetta, Director of IBM Research, stated that the transition validates the company's technical roadmap. IBM has publicly committed to delivering its first fault-tolerant system, dubbed Quantum Starling, by 2029. While previous stages of the DARPA program focused on R&D plans and risk mitigation, Stage C mandates that participants undergo independent testing of their hardware, systems engineering, and architecture.

Transition to Hardware Validation

IBM currently manages a global fleet of quantum systems supported by Qiskit software, serving a network of over 340 organizations across sectors including healthcare and finance. The company’s recent progress includes successful demonstrations of error correction decoding and core hardware components designed for fault tolerance. By moving into the evaluation phase, IBM joins a select group of performers tasked with proving that the computational value of their quantum systems will eventually exceed the costs of development and operation.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!